US FDA Generic Drug Approvals, Other Actions Declined As Approval Times Climbed In FY 2024

 
• By Derrick Gingery
  
Exterior view of the headquarters of US Food and Drug Administration (FDA). This federal agency approves medication.
The FY 2024 generic drugs activity data likely will inform user fee reauthorization negotiations, which will begin in 2025. • Source: Alamy

More from Regulation

More from Generics Bulletin